1993
DOI: 10.1097/00001432-199302000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology, therapy, and prevention of infection with Shigella organisms and Clostridium difficile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

1995
1995
2011
2011

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…Overall, nalidixic acid is effective in the majority of patients with shigellosis who receive therapy at both hospitals and the urban community in the northeast of Brazil. Thus, the presumptive treatment for shigellosis in our hospitals and community areas has become nalidixic acid (25,33). Indeed, in most developing countries, treatment of shigellosis must of necessity be empirical because facilities for routine culture of stool samples are not available.…”
Section: Downloaded Frommentioning
confidence: 99%
“…Overall, nalidixic acid is effective in the majority of patients with shigellosis who receive therapy at both hospitals and the urban community in the northeast of Brazil. Thus, the presumptive treatment for shigellosis in our hospitals and community areas has become nalidixic acid (25,33). Indeed, in most developing countries, treatment of shigellosis must of necessity be empirical because facilities for routine culture of stool samples are not available.…”
Section: Downloaded Frommentioning
confidence: 99%
“…Lima e Lima 25 relatam que ácido nalidíxico é um antimicrobiano eficaz na terapêutica contra shigelose, em se tratando de cepas resistentes a outros antimicrobianos comumente empregados. Para essas cepas de Shigella spp.…”
Section: Discussionunclassified
“…During the last 20 years the number of diseases related to C. difficile, especially the nosocomial diarrhea, has been steadily growing [4][5][6][7][8][9]. The majority of the toxigenic strains of C. difficile, whose toxigenicity was described initially in 1935 [10], yield two types of exotoxins, toxin A (TxA) and toxin B (TxB), heat-labile proteins of 308-and 270-kDa MW respectively, both playing an active role on establishing or aggravating the clinical evolution of nosocomial diarrhea [7,11].…”
Section: Introductionmentioning
confidence: 99%